RG
Robert Goldman
Co-Founder & President at Peprotech
View Robert's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Co-Founder & President
Present
Company Details
51-200 Employees
PeproTech was established in 1988 by a group of scientists who decided to focus their efforts on the development and production of recombinant cytokines for life-science research. Today, we are a business unit within the Thermo Fisher Scientific BioSciences Division. Our team is dedicated to advancing solutions that enable our customers to accelerate research and discovery to solve the world’s most complex scientific challenges. PeproTech specializes in manufacturing and supplying high quality cytokine products and exceptional service to the life science and cell therapy markets around the world. Our products are distributed worldwide through customer-service offices in the US, UK, France, Germany, Israel, Korea, China and Japan. A key component in keeping up with current scientific advancements has been our collaboration with researchers in both academia and industry. We encourage you to convey to us your particular research needs and promise to do our best to fulfil them. Part of Thermo Fisher Scientific, the world leader in serving science.
Year Founded
1988
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research, Food Processing, Food & Related Products, Pharmaceuticals - basic and auxiliary products, Monoclonal Antibodies, Drugs, Vitamins & Supplements, Other, Polyclonal Antibodies, Acacia Extract, Eiweiße
HQ Location
5 Cedarbrook Dr Cranbury, New Jersey 08512, US
Keywords
CytokinesGrowth FactorsChemokinesStem Cell Growth FactorsAntibodiesELISA Development KitsAnimal-Free CytokinesCell Culture Media/SupplementsGMP Cytokines for CellGene and Tissue Therapy
Discover More About Cleveland Clinic

Find verified contacts of Robert Goldman in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.